Sign in
4/A

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-25-000090

Options or other derivatives

  • Chief Financial Officer acquired 750,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nguyen Tuan · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +750,000 750,000 D
Loading xslF345X05/wk-form4a_1743544061.xml…